₹90.90
(Market cap
₹1,235 Cr
Revenue (TTM)
₹153 Cr
P/E Ratio
22.2
P/B Ratio
4.4
Div. Yield
0.3 %
Quality Score
8/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
3/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹56 Cr
-
ROE
19.4 %
-
ROCE
26 %
-
Industry P/E
22.24
-
EV/EBITDA
14.1
-
Debt to Equity
0
-
Book Value
₹326.2
-
EPS
₹64.7
-
Face value
10
-
Shares outstanding
8,582,670
10 Years Aggregate
CFO
₹239.60 Cr
EBITDA
₹325.32 Cr
Net Profit
₹269.62 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
| -- | 11.5 | 18.0 | -- | -- | -- | -- |
|
BSE Commodities
| 9.7 | 2.7 | -1.2 | 13.5 | 16.4 | 9.7 | 14.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
3B Blackbio Dx
|
1,441.2 | 1,234.8 | 153.2 | 56.3 | 30.9 | 17.8 | 22.2 | 4.4 |
| 4,048.7 | 18,202.5 | 5,595.4 | 732.1 | 13.9 | 24 | 24.9 | 5.5 | |
| 277.9 | 3,600.3 | 607.2 | 27.5 | 8.8 | 4 | 130.8 | 5.1 | |
| 1,255.2 | 2,087.4 | 1,202.6 | 135.9 | 12.4 | 11.8 | 14.6 | 1.6 | |
| 976.1 | 4,350.0 | 1,953.4 | 268.0 | 16.0 | 16.6 | 16.2 | 2.6 | |
| 598.5 | 1,739.3 | 2,060.4 | 124.8 | 8.4 | 10.3 | 13.9 | 1.4 | |
| 171.6 | 4,022.0 | 1,519.4 | 12.4 | 4.8 | 3.4 | 325.1 | 5.7 | |
| 209.6 | 4,080.9 | 2,962.0 | 214.0 | 9.4 | 13.5 | 19.1 | 1.9 | |
| 783.8 | 7,072.4 | 5,356.5 | 626.2 | 13.1 | 21.5 | 11.3 | 2.2 | |
| 517.9 | 25,848.3 | 3,244.9 | 579.4 | 19.0 | 17.3 | 44.6 | 7.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About 3B Blackbio Dx
Kilpest India Limited, an agriculture based company, manufactures and sells pesticides and other agrochemical products in India. Its chemical products include insecticides, anti-bacterial, fungicides, herbicides/weedicides, and public health... products; and biological products comprise bio pesticides, bio fungicides, bio fertilizers, bio nematicides, and health and hygiene related products, as well as micro fertilizers and plant growth stimulants. The company also exports its products to Bangladesh and Afghanistan. In addition, it offers a range of diagnostic kits for various diseases ranging from infectious diseases to oncology. The company was founded in 1972 and is based in Bhopal, India. Read more
-
Incorporated
1972
-
Chairman
Dhirendra Dubey
-
Managing Director
Dhirendra Dubey
-
Headquarters
Bhopal, Madhya Pradesh
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for 3B Blackbio Dx
What is the current share price of 3B BlackBio Dx Ltd Today?
The share price of 3B BlackBio Dx Ltd is ₹1,441.20 (NSE) and ₹1,438.75 (BSE) as of 28-Aug-2026 IST. 3B BlackBio Dx Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of 3B BlackBio Dx Ltd?
The P/E ratio of 3B BlackBio Dx Ltd is 22.24 times as on 28-Aug-2026, a 0 premium to its peers’ median range of 22.24 times.
The P/B ratio of 3B BlackBio Dx Ltd is 4.41 times as on 28-Aug-2026, a 67 premium to its peers’ median range of 2.64 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
29.05 |
5.16 |
2024 |
20.54 |
2.96 |
2023 |
13.73 |
1.84 |
2022 |
7.94 |
1.67 |
2021 |
1.87 |
1.62 |
What is the 52 Week High and Low of 3B BlackBio Dx Ltd?
The 52-week high and low of 3B BlackBio Dx Ltd are Rs 1,463.00 and Rs 1,085.00 as of 31-Aug-2026.
What is the market cap of 3B BlackBio Dx Ltd?
3B BlackBio Dx Ltd has a market capitalisation of ₹ 1,235 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in 3B BlackBio Dx Ltd?
Before investing in 3B BlackBio Dx Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.